Currently, very few heritable diseases have gene therapies that have been approved by the FDA. One therapy, called Zolgensma, treats spinal muscular atrophy in newborns and children up to age two. But halting the disease in childhood may still be too late to avoid lifelong health issues. “When the baby is born, in the most severe […]